meclizine and semaglutide Weight Loss Program – Healthogenics contain semaglutide Ozempic® (semaglutide) and Mounjaro™ (tirzepatide),

(B) Axial image from pre-semaglutide scan at L3 level shows color-coded tissue segmentations

Who should you ask for a referral

Symptoms of a bowel obstruction include: Severe constipation Bloating Vomiting Abdominal pain and cramps Lack of appetite Feeling generally unwell Diarrhea Signs of dehydration, such as rapid heartbeat and darker-colored urine If you have symptoms of bowel obstruction, seek medical attention immediately

contraindicated with personal/family history of MEN2 or medullary thyroid carcinoma Dose escalation principle / slow titration (4-week steps) reduces GI burden Key contraindication / personal or family history of medullary thyroid carcinoma or MEN2 syndrome Weight-loss benchmark / semaglutide 2.4 mg: 14.9% mean body weight loss at 68 weeks (STEP-1, N=1,961) Cardiovascular benefit / semaglutide reduced MACE by 20% vs